Dr. Alexandra Sowa discusses the risks and benefits of using popular weight loss drugs like Ozempic and Wegovy. Sowa says the ...
The FDA wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies ...
Pharmaceutical giants are squaring off against telehealth companies and pharmacies selling custom-made versions of the hot ...
Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...
The FBI is raising concerns about fraud related to popular weight loss drugs such as Ozempic and Wegovy in this Community ...
Novo Nordisk A/S (NYSE:NVO) returned to full membership of the Association of the British Pharmaceutical Industry (ABPI) ...
BRINP2-related peptide, or BRP, is a naturally occurring molecule that can suppress appetite and promote weight loss in mice ...
A new study links semaglutide, the active ingredient in Ozempic and Wegovy, to a higher risk of hair loss, especially in ...
Drugs like Ozempic and Wegovy could raise the risk of a rare form of vision loss, but we are still trying to unpick why ...
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...
The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...
US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results